Myc Monoclonal Antibody [PPMYCSHG] (CPAB0736)
- SKU:
- CPAB0736
- Product Type:
- Antibody
- Antibody Type:
- Monoclonal Antibody
- Reactivity:
- Universal
- Clone:
- PPMYCSHG
- Applications:
- WB
Description
Myc Monoclonal Antibody [PPMYCSHG] (CPAB0736)
The Myc Polyclonal Antibody (CPAB0736) is a valuable tool for researchers studying the Myc protein, a key regulator of cell growth and proliferation. This antibody, produced in rabbits, shows high reactivity with human samples and is validated for use in Western blot applications. By binding specifically to the Myc protein, researchers can accurately analyze and detect its expression in various cell types.The Myc protein, a transcription factor, plays a crucial role in regulating cell cycle progression and cell differentiation. Dysregulation of the Myc gene is commonly found in various types of cancer, making it a target of interest for cancer researchers.
Studying the expression and activity of the Myc protein can provide insights into the mechanisms underlying oncogenesis and potential therapeutic strategies.Overall, the Myc Polyclonal Antibody is a valuable tool for researchers investigating the role of the Myc protein in cancer development and progression. Its specificity and reactivity make it an essential component in studies aimed at understanding the molecular pathways involving Myc and its implications in cancer biology.
Product Name: | Myc Antibody |
Product Sku: | CPAB0736 |
Size: | 100μl |
Host Species: | |
Immunogen: | |
Clone: | PPMYCSHG. |
Reactivity: | Other Polyclonal bodies |
Applications: | Western Blot |
Purification Method: | |
Isotype: | |
Background: | c-Myc is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. It functions as a transcription factor that regulates transcription of specific target genes. Mutations, overexpression, rearrangement and translocation of c-Myc have been associated with a variety of hematopoietic tumors, leukemias and lymphomas, including Burkitt lymphoma. There is evidence to show that alternative translation initiations from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site result in the production of two isoforms with distinct N-termini. The synthesis of non-AUG initiated protein is suppressed in Burkitt's lymphomas, suggesting its importance in the normal function of this gene. |
Synonyms: | MYC, CMYC, C-MYS, V-MYC, P64. |
Storage Buffer: |